Publications

Cascavita CT, Hall AE, Shariati K, Chevalier JM, Argame AA, Nguyen NH, Tseng CH, Hidalgo MA, Lee JC; Craniofacial Outcomes Research Team. Exercise- and Nutrition-Based[...]

Mouabbi JA, Lipsyc-Sharf MD, Yan F. Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):1-16.[...]

Lipsyc-Sharf MD. Interpreting MRD results and integrating assays into practice. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):7-11. PMID: 42283708.

Mouabbi JA, Lipsyc-Sharf MD, Yan F. Practical approach to MRD testing in breast cancer: Q&A. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):11-15. PMID: 42283709.

Mathews M, Martino SC, Agniel D, Hernandez HG, Beckett MK, Saliba D, Dembosky JW, Orr N, Elliott MN. Use of Claims Data to Screen for[...]

Delanaye P, Pottel H, Glassock RJ. GFR indexing per Body surface area -Why, how and when? Nephrol Dial Transplant. 2026 Jun 12:gfag138. doi: 10.1093/ndt/gfag138. Epub[...]

Wander SA, Weipert CM, Cabel L, Liao J, Zhang N, Safonov A, Bardia A, Razavi P. Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6[...]

Aggarwal H, Gupta N, Sengupta A, Sarkar A, Mylavarapu S, Pires IS, Saha T, Sarkar B, Kulkarni A, Mahajan VS, Goyal L, Bardia A, Fahrner[...]

Sato N, Okami S, Yoshikawa-Ryan K, Yamashita S, Kobayashi R, Arita Y, Kim SW, Knapp R, Holl K, Fonarow GC. Pharmacological treatments and clinical events[...]

Armstrong AW, Bin Sawad A, Hazra NC, Balu S, Maslin D, Libchaber B, Huang R, Gauthier-Loiselle M, Guerin A. Patient Preferences for Treatment Attributes in[...]